FibroBiologics, Inc. Common Stock

FBLG XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

5.5M

Short interest (May 15)

4.6%

Net Short (Jun 03 ): 0.7%

Borrow Fee

74.27%

↓ 10.9%

Available Shares

600K

↓ 13.7%

Price Chart

Company Overview

FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001958777

Asset Type: CS

Market Data

Market Cap: $5,469,360

Employees: 15

Status: Active

Short Interest

Current Borrow Fee 74.27%

Range: 70.63% - 74.27%

Available Shares 600K

Range: 300K - 550K

Recent Changes

Fee Change: ↓ 5.7%

Available Change: ↓ 8.3%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime